Verily adn NVIDIA Partner to Revolutionize Healthcare AI with Accelerated Omics and Data Analysis
The landscape of healthcare is undergoing a rapid conversion, fueled by the power of artificial intelligence. Today, verily, a leading precision health AI company, announced a strategic collaboration with NVIDIA to dramatically accelerate AI development and deployment across the healthcare ecosystem. This partnership isn’t just about integrating technology; it’s about unlocking new possibilities for researchers, clinicians, and ultimately, patients.
What Does This Mean for Healthcare?
This collaboration centers around integrating NVIDIA’s complete AI technology stack into Verily’s Pre platform. This means Verily’s extensive network of health system, life science, payer, and government partners will gain access to cutting-edge tools designed to streamline and enhance AI initiatives. The goal? to move from lengthy research cycles to rapid, impactful solutions.
Unprecedented Speed for Omics and AI Research
for researchers, this partnership translates to immediate access to state-of-the-art hardware and software within Verily’s trusted research surroundings, Workbench.
here’s what’s now available:
* Next-Generation GPUs: Access to the latest NVIDIA GPUs, including the powerful Blackwell and Hopper architectures.
* Accelerated Libraries & Frameworks: Integration of NVIDIA’s GPU-accelerated libraries and frameworks like NeMo, Parabricks, and CUDA-X Data Science.
* Dramatic Performance Gains: Early results are compelling. Using NVIDIA Parabricks and B200 GPUs, genomic data processing that once took hours is now completed in minutes compared to conventional CPU-based methods.
“With NVIDIA’s cutting-edge AI capabilities now available in our Pre platform, we are providing researchers with unparalleled tools to enhance the speed and efficiency of AI model development and omics analysis,” explains Stephen Gillett, Verily CEO.This isn’t incremental improvement; it’s a paradigm shift.
Powering the Future of Genomic Research: The NIH All of Us Program
The impact of this collaboration extends to large-scale, nationally significant research initiatives. A key focus is accelerating analyses within the National Institutes of Health’s (NIH) All of Us Researcher Workbench.
This Workbench is a cornerstone of genomic research, hosting one of the world’s largest genomics datasets and supporting nearly 20,000 researchers globally. Through Verily’s partnership with Vanderbilt University Medical Center, the Pre platform will now power this vital resource.
To demonstrate the platform’s capabilities, Verily researchers recently developed the first multimodal foundation model using the All of Us dataset. This groundbreaking model integrates electronic health records (EHR) with genomics data via polygenic risk scores, offering the potential for earlier disease prediction and proactive health management. Crucially, this model was trained ten times faster than previous approaches, leveraging NVIDIA NeMo Automodel and H100 GPUs.
Expanding AI Across the Pre Platform Ecosystem
The integration doesn’t stop at Workbench. Verily plans to extend NVIDIA GPU-accelerated tools across its entire Pre platform, enhancing capabilities in key areas:
* Refinery: This powerful curation engine transforms unstructured data into structured, clinically relevant data assets. It ingests, harmonizes, and enriches multimodal data using a FHIR-native data model.
* Exchange: A secure and collaborative environment for sharing and accessing AI-ready datasets, models, and agents, fostering innovation in precision research and care.
What’s Next?
The Verily and NVIDIA partnership represents a significant leap forward in healthcare AI. By democratizing access to advanced AI tools and accelerating data analysis, this collaboration promises to unlock new insights, improve patient outcomes, and reshape the future of healthcare.This isn’t just about faster processing; it’s about realizing the full potential of precision medicine.
Keep reading